The organization's own name translates as 'data and analytics', and both projects — EPP-eHealth and MULTI-ACT — are coordination actions where analytical capacity is the likely contribution.
DANE-I-ANALIZY.PL SP ZOO
Polish data analytics firm with EU project experience in digital health procurement and research impact measurement across 10 countries.
Their core work
Dane-i-analizy.pl (Polish for "data and analytics") is a Kraków-based private analytics firm that contributes data analysis and market intelligence capabilities to European coordination and support projects. Their H2020 track record shows involvement in two distinct CSA-type initiatives: one focused on transforming public procurement markets for digital health solutions, and one on building frameworks for measuring research impact and engaging non-academic actors. This profile — no coordination roles, CSA-only schemes — points to a consultancy or analytics company that brings structured data work to multi-stakeholder coordination efforts rather than conducting primary research. They appear to operate as a specialist analytics contributor embedded within larger European consortia.
What they specialise in
EPP-eHealth (2015-2016) aimed to transform the market for eHealth solutions through a European Procurers Platform, requiring market analysis and procurement data expertise.
MULTI-ACT (2018-2021) developed a collective research impact framework with multi-variate models to foster engagement of diverse actors, suggesting expertise in impact measurement methodology.
MULTI-ACT explicitly involved multi-variate models for measuring collective research impact, indicating quantitative modelling capabilities beyond basic analytics.
How they've shifted over time
This organization's short H2020 history spans two distinct thematic phases. In 2015-2016 their work centred on practical digital market problems — specifically how public procurement can reshape the eHealth solutions market, a topic at the intersection of data, policy, and health systems. By 2018-2021 they had moved toward abstract framework-building: measuring research impact across society and designing models for multi-actor engagement, a much more methodological and governance-oriented domain. The shift from applied market transformation to research impact theory suggests the firm may be broadening its consultancy offer from sector-specific analytics toward cross-cutting policy and evaluation work.
Their trajectory points toward evaluation methodology and impact assessment consultancy — a growing demand area as EU institutions and funders increasingly require evidence of societal return on research investment.
How they like to work
Dane-i-analizy.pl has participated in every project as a non-leading partner and has never held coordinator status across its two H2020 projects. Despite a small project count, they have engaged with 17 unique consortium partners across 10 countries, suggesting they slot efficiently into diverse European consortia without dominating them. This profile is characteristic of a specialist analytics firm brought in to provide a defined capability — data work, modelling, or market intelligence — within coordination projects led by larger institutions.
The organization has built connections with 17 distinct partners across 10 countries from only two projects — an unusually broad network for such a small portfolio, likely reflecting the multi-stakeholder nature of CSA-type coordination actions. No geographic concentration is evident from the available data.
What sets them apart
Among Polish private companies in H2020, dane-i-analizy.pl occupies a narrow but useful niche: a data analytics firm that participates in coordination and support actions where analytical rigour is needed but rarely the core focus of larger research partners. Their dual exposure to digital health markets and research impact evaluation gives them cross-domain credibility that pure sector specialists lack. For a consortium needing a data-capable partner that will not compete for leadership, they represent a low-friction, high-specificity option.
Highlights from their portfolio
- MULTI-ACTThe largest grant in their portfolio (EUR 298,750) and the more methodologically ambitious project — developing multi-variate models for collective research impact, a topic with growing relevance across EU funding programmes.
- EPP-eHealthTheir earliest H2020 engagement placed them inside a European-scale initiative to reshape public procurement for eHealth, demonstrating early positioning at the policy-data interface in digital health.